Literature DB >> 18606873

Glycerolipid metabolism and signaling in health and disease.

Marc Prentki1, S R Murthy Madiraju.   

Abstract

Maintenance of body temperature is achieved partly by modulating lipolysis by a network of complex regulatory mechanisms. Lipolysis is an integral part of the glycerolipid/free fatty acid (GL/FFA) cycle, which is the focus of this review, and we discuss the significance of this pathway in the regulation of many physiological processes besides thermogenesis. GL/FFA cycle is referred to as a "futile" cycle because it involves continuous formation and hydrolysis of GL with the release of heat, at the expense of ATP. However, we present evidence underscoring the "vital" cellular signaling roles of the GL/FFA cycle for many biological processes. Probably because of its importance in many cellular functions, GL/FFA cycling is under stringent control and is organized as several composite short substrate/product cycles where forward and backward reactions are catalyzed by separate enzymes. We believe that the renaissance of the GL/FFA cycle is timely, considering the emerging view that many of the neutral lipids are in fact key signaling molecules whose production is closely linked to GL/FFA cycling processes. The evidence supporting the view that alterations in GL/FFA cycling are involved in the pathogenesis of "fatal" conditions such as obesity, type 2 diabetes, and cancer is discussed. We also review the different enzymatic and transport steps that encompass the GL/FFA cycle leading to the generation of several metabolic signals possibly implicated in the regulation of biological processes ranging from energy homeostasis, insulin secretion and appetite control to aging and longevity. Finally, we present a perspective of the possible therapeutic implications of targeting this cycling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606873     DOI: 10.1210/er.2008-0007

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  104 in total

1.  Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high-fat-diet feeding.

Authors:  Aparna Purushotham; Qing Xu; Xiaoling Li
Journal:  FASEB J       Date:  2011-10-17       Impact factor: 5.191

2.  Redundancy control in pathway databases (ReCiPa): an application for improving gene-set enrichment analysis in Omics studies and "Big data" biology.

Authors:  Juan C Vivar; Priscilla Pemu; Ruth McPherson; Sujoy Ghosh
Journal:  OMICS       Date:  2013-06-11

3.  Role of lactate in lipid metabolism, just always inhibiting lipolysis?

Authors:  Hai-Jun Xu
Journal:  J Biol Chem       Date:  2009-07-31       Impact factor: 5.157

4.  Ablation of calcineurin Aβ reveals hyperlipidemia and signaling cross-talks with phosphodiesterases.

Authors:  Hee Yun Suk; Chen Zhou; Teddy T C Yang; Hong Zhu; Raymond Y L Yu; Opeyemi Olabisi; XiaoYong Yang; Deborah Brancho; Ja-Young Kim; Philipp E Scherer; Philippe G Frank; Michael P Lisanti; John W Calvert; David J Lefer; Jeffery D Molkentin; Alessandra Ghigo; Emilio Hirsch; Jianping Jin; Chi-Wing Chow
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

5.  Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Authors:  V Delghingaro-Augusto; C J Nolan; D Gupta; T L Jetton; M G Latour; M Peshavaria; S R Murthy Madiraju; E Joly; M-L Peyot; M Prentki; J Leahy
Journal:  Diabetologia       Date:  2009-03-18       Impact factor: 10.122

Review 6.  Cellular fatty acid uptake: a pathway under construction.

Authors:  Xiong Su; Nada A Abumrad
Journal:  Trends Endocrinol Metab       Date:  2009-01-29       Impact factor: 12.015

7.  Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.

Authors:  Marie-Line Peyot; Joshua P Gray; Julien Lamontagne; Peter J S Smith; George G Holz; S R Murthy Madiraju; Marc Prentki; Emma Heart
Journal:  PLoS One       Date:  2009-07-13       Impact factor: 3.240

8.  Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts.

Authors:  Johanna Tuomela; Tove J Grönroos; Maija P Valta; Jouko Sandholm; Aleksi Schrey; Jani Seppänen; Päivi Marjamäki; Sarita Forsback; Ilpo Kinnunen; Olof Solin; Heikki Minn; Pirkko L Härkönen
Journal:  BMC Cancer       Date:  2010-10-30       Impact factor: 4.430

9.  Deletion of PKCepsilon selectively enhances the amplifying pathways of glucose-stimulated insulin secretion via increased lipolysis in mouse beta-cells.

Authors:  James Cantley; James G Burchfield; Gemma L Pearson; Carsten Schmitz-Peiffer; Michael Leitges; Trevor J Biden
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Deletion of GPR40 impairs glucose-induced insulin secretion in vivo in mice without affecting intracellular fuel metabolism in islets.

Authors:  Thierry Alquier; Marie-Line Peyot; Martin G Latour; Melkam Kebede; Christina M Sorensen; Stephane Gesta; C Ronald Kahn; Richard D Smith; Thomas L Jetton; Thomas O Metz; Marc Prentki; Vincent Poitout
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.